A Management Algorithm for Mitomycin C Induced Cystitis
Bladder Cancer · 11.04.2017 · 3 (2) · 133-138
DOI: 10.3233/blc-160089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bladder Cancer, online erschienen am 11.04.2017. Verfasst von Amy N Luckenbaugh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Michigan Health System, Ann Arbor, MI, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background/Objective: A post-bladder tumor resection dose of MMC can reduce non-invasive papillary (pTa) bladder cancer recurrences by up to 40%; this treatment is recommended in both the AUA and EUA non-muscle-invasive bladder cancer guidelines. A common complication of this treatment is eosinophilic cystitis. Symptoms range from mild urinary frequency and urgency to debilitating pain and dysuria. Currently, there is no established treatment algorithm for MMC-induced cystitis.
Methods
Members of the Urologic Surgery Quality Collaborative (USQC), a group composed of over 160 private and academic urologists, met to discuss the management of patients with cystitis following MMC therapy. They devised a treatment algorithm based on experiences of urologic oncologists and neurourologists to aid in the diagnosis and management of MMC-induced cystitis.
Results
The assessment begins with urinalysis and culture, followed by cystoscopy. For mild symptoms, behavioral therapy, including timed voids, fluid restriction and Kegel exercises are trialed. If symptoms have not resolved, treatment with an antihistamine, followed by a combination of anticholinergic and alpha-blocker medications. For persistent symptoms or severe symptoms at presentation, a course of prednisone plus antihistamine is prescribed. If symptoms are improving but have not resolved, this treatment is extended for a full 4 weeks prior to steroid taper. If symptoms do not improve, any visible bladder ulcerations are resected intraoperatively followed by an additional course of prednisone and antihistamine. Intravesical DMSO instillations and intra-ulcer steroid injection can be used as a final effort to treat this condition.
Conclusion
We present the first formal management algorithm with escalating treatment intensity tailored to patient symptoms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University of Michigan Health System, Ann Arbor, MI, USA.
- Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA.
Zitieren
APA
Luckenbaugh, A. N., Marks, R. M., Miller, D. C., Weizer, A. Z., Stoffel, J. T., & Montgomery, J. S. (2017). A Management Algorithm for Mitomycin C Induced Cystitis. Bladder Cancer, 3(2), 133-138. https://doi.org/10.3233/blc-160089
Vancouver
Luckenbaugh AN, Marks RM, Miller DC, Weizer AZ, Stoffel JT, Montgomery JS. A Management Algorithm for Mitomycin C Induced Cystitis. Bladder Cancer. 2017;3(2):133-138. doi:10.3233/blc-160089
BibTeX
@article{Luckenbaugh2017,
author = {Luckenbaugh, Amy N and Marks, Rory M and Miller, David C and Weizer, Alon Z and Stoffel, John T and Montgomery, Jeffrey S},
title = {A Management Algorithm for Mitomycin C Induced Cystitis},
journal = {Bladder Cancer},
year = {2017},
volume = {3},
number = {2},
pages = {133--138},
doi = {10.3233/blc-160089}
}
EUVIMED